Comparison of Indirect Calorimetry by Q-NRG With Deltatrac II

June 25, 2023 updated by: Anne-Françoise Rousseau, University of Liege

Comparison of Indirect Calorimetry by Q-NRG With Deltatrac II in Healthy Volunteers

Comparison of indirect calorimetry by Q-NRG (Cosmed) with Deltatrac II (Datex)

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

The aim of the present study is to compare the measured resting energy expenditure by Q-NRG (Cosmed) with Deltatrac II (Datex), in healthy volunteers.

Q-NRG is a new device. It is relevant to compare its results with the blog standard calorimeter, the Deltratrac II.

The study will include sports healthy subjects. The could benefit from the determination of their resting energy expenditure in order to adapt their nutritional intakes.

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Healthy volunteers who practice more than 1 hour per day at moderate intensity

Description

Inclusion Criteria:

  • healthy adult
  • sport practice > 1h per day at moderate intensity

Exclusion Criteria:

  • refusal to participate
  • unable to give a consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
resting energy expenditure
Time Frame: during the calorimetry
comparison of resting energy expenditure measured using Q-NRG calorimeter with resting energy expenditure measured using Deltatrac II
during the calorimetry

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anne-Françoise Rousseau, MD, PhD, University Hospital of Liège, Belgium

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 31, 2021

Primary Completion (Actual)

April 30, 2022

Study Completion (Estimated)

July 1, 2023

Study Registration Dates

First Submitted

July 9, 2021

First Submitted That Met QC Criteria

August 16, 2021

First Posted (Actual)

August 17, 2021

Study Record Updates

Last Update Posted (Actual)

June 27, 2023

Last Update Submitted That Met QC Criteria

June 25, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • B7072021000024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Indirect Calorimetry

Clinical Trials on no drug

Subscribe